Dr. Aidun joined the Woodruff School as a Professor in 2003 after completion of a two-year period as program director at the National Science Foundation. He began at Tech in 1988 as an Assistant Professor at the Institute of Paper Science and Technology. Prior, he was a research Scientist at Battelle Research Laboratories, Postdoctoral Associate at Cornell University and Senior Research Consultant at the National Science Foundation's Supercomputer Center at Cornell. 

Dr. Aidun's research is at the intersection between fundamentals of the physics of complex fluids/thermal transport and applications to engineering and biotransport. He has a diverse research portfolio in fluid mechanics, bioengineering, renewable bioproducts and decarbonization of industrial processes. 

A major focus has been to understand the physics of blood cell transport and interaction with glycoproteins (e.g., vWF) with applications to cardiovascular diseases.

Amirali Aghazadeh is an Assistant Professor in the School of Electrical and Computer Engineering and also program faculty of Machine Learning, Bioinformatics, and Bioengineering Ph.D. programs. He has affiliations with the Institute for Data Engineering and Science (IDEAS) and Institute for Bioengineering and Biosciences. Before joining Georgia Tech, Aghazaeh was a postdoc at Stanford and UC Berkeley and completed his Ph.D. at Rice University. His research focuses on developing machine learning and deep learning solutions for protein and small molecular design and engineering.
 

Vinny is an Assistant Professor at Georgia Tech with joint appointments at the School of Chemistry and Biochemistry and School of Biological Sciences.

A majority of antibiotics and drugs that we use in the clinic are derived or inspired from small organic molecules called Natural Products that are produced by living organisms such as bacteria and plants. Natural Products are at the forefront of fighting the global epidemic of antibiotic resistant pathogens, and keeping the inventory of clinically applicable pharmaceuticals stocked up. Some Natural Products are also potent human toxins and pollutants, and we need to understand how these toxins are produced to minimize our and the environmental exposure to them.

We as biochemists ask some simple questions- how and why are Natural Products produced in Nature, what we can learn from Natural Product biosynthetic processes, and how we can exploit Nature's synthetic capabilities for interesting applications?

Broadly, we are interested in questions involving (meta)genomics, biochemistry, structural and mechanistic enzymology, mass spectrometry, analytical chemistry, and how natural product chemistry dictates biology.

Alex Adams’s research focuses on designing, fabricating, and implementing new ubiquitous and wearable sensing systems. In particular, he is interested in how to develop these systems using equity-driven design principles for healthcare. Alex leverages sensing, signal processing, and fabrication techniques to design, deploy, and evaluate novel sensing technologies.

Originally a musician, Alex became fascinated by how he could capture and manipulate sounds through analog hardware and digital signal processing, which led him back to his hometown (Concord, NC). Alex completed his BS at the University of North Carolina at Charlotte in 2014 and his Ph.D. at Cornell University in 2021 (advised by Professor Tanzeem Choudhury). Alex then became the resident Research Scientist for the Precision Behavioral Health Initiative at Cornell Tech (NYC) until the fall of 2022, when he joined the School of Interactive Computing at the Georgia Institute of Technology. Currently, his research focuses on the equity-driven design and the development of multi-modal sensing systems to simultaneously assess mental and physical health to enable a new class of mobile health technologies.

Alex Abramson is an assistant professor in the School of Chemical and Biomolecular Engineering at Georgia Tech. His research, which focuses on drug delivery and bioelectronic therapeutics, has been featured in news outlets such as The New York Times, NPR, and Wired. Abramson has received several recognitions for scientific innovation, including being named a member of the Forbes 30 Under 30 Science List and the MIT Technology Review Innovators Under 35 List. He is passionate about translating scientific endeavors from bench to bedside. Large pharmaceutical companies have exclusively licensed a portfolio of his patents to bring into clinical trials, and Abramson serves as a scientific advisor overseeing their commercialization. In addition to his scientific endeavors, Abramson plays an active role in his community by leading diversity and inclusion efforts on campus and volunteering as a STEM tutor to local students.

Abramson received a B.S. in chemical and biomolecular engineering from Johns Hopkins University and a Ph.D. in chemical engineering from MIT as an NSF Graduate Research Fellow under the direction of Professors Robert Langer and Giovanni Traverso. He conducted postdoctoral work at Stanford University as an NIH fellow with Professors Zhenan Bao and the late Sanjiv S. Gambhir.

The Abramson Lab develops ingestible, implantable, and wearable robotic therapeutic devices that solve key healthcare problems and provide measurable therapeutic outcomes. Our translationally focused research spans a multitude of areas, including (1) drug delivery devices for optimal drug adherence, (2) soft materials for bioelectronic sensors and therapeutics, and (3) preclinical drug screening technologies.